Botulism-Pipeline Review, H1 2015

Botulism-Pipeline Review, H1 2015

  • Products Id :- GMDHC6077IDB
  • |
  • Pages: 34
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Botulism-Pipeline Review, H1 2015


Global Markets Direct's, 'Botulism-Pipeline Review, H1 2015', provides an overview of the Botulism's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Botulism, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Botulism and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides a snapshot of the global therapeutic landscape of Botulism

The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

The report reviews key players involved in the therapeutics development for Botulism and enlists all their major and minor projects

The report summarizes all the dormant and discontinued pipeline projects

A review of the Botulism products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

A detailed assessment of monotherapy and combination therapy pipeline projects

Coverage of the Botulism pipeline on the basis of target, MoA, route of administration and molecule type

Latest news and deals relating related to pipeline products

Reasons To Buy

Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop strategic initiatives by understanding the focus areas of leading companies

Identify and understand important and diverse types of therapeutics under development for Botulism

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Devise corrective measures for pipeline projects by understanding Botulism pipeline depth and focus of Indication therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Introduction 5

Global Markets Direct Report Coverage 5

Botulism Overview 6

Therapeutics Development 7

Pipeline Products for Botulism-Overview 7

Pipeline Products for Botulism-Comparative Analysis 8

Botulism-Therapeutics under Development by Companies 9

Botulism-Pipeline Products Glance 10

Early Stage Products 10

Botulism-Products under Development by Companies 11

Botulism-Companies Involved in Therapeutics Development 12

AlphaVax, Inc. 12

Hawaii Biotech, Inc. 13

Microbiotix, Inc. 14

Molecular Targeting Technologies, Inc. 15

Planet Biotechnology Inc. 16

Botulism-Therapeutics Assessment 17

Assessment by Monotherapy Products 17

Assessment by Target 18

Assessment by Mechanism of Action 19

Assessment by Molecule Type 20

Drug Profiles 22

Botulinum Neurotoxin Vaccine (Multivalent)-Drug Profile 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

botulinum toxin vaccine-Drug Profile 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

botulinum vaccine-Drug Profile 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

Botulism Vaccine-Drug Profile 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

Monoclonal Antibodies to Inhibit Botulinum Neurotoxin for Botulism-Drug Profile 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

Recombinant Peptides to Inhibit Botulinum Toxin for Botulism-Drug Profile 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

Small Molecules for Botulism-Drug Profile 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

Small Molecules to Inhibit BoNT/A LC for Botulism-Drug Profile 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

Botulism-Dormant Projects 31

Botulism-Discontinued Products 32

Appendix 33

Methodology 33

Coverage 33

Secondary Research 33

Primary Research 33

Expert Panel Validation 33

Contact Us 34

Disclaimer 34

List of Tables

Number of Products under Development for Botulism, H1 2015 7

Number of Products under Development for Botulism-Comparative Analysis, H1 2015 8

Number of Products under Development by Companies, H1 2015 9

Comparative Analysis by Early Stage Development, H1 2015 10

Products under Development by Companies, H1 2015 11

Botulism-Pipeline by AlphaVax, Inc., H1 2015 12

Botulism-Pipeline by Hawaii Biotech, Inc., H1 2015 13

Botulism-Pipeline by Microbiotix, Inc., H1 2015 14

Botulism-Pipeline by Molecular Targeting Technologies, Inc., H1 2015 15

Botulism-Pipeline by Planet Biotechnology Inc., H1 2015 16

Assessment by Monotherapy Products, H1 2015 17

Number of Products by Stage and Target, H1 2015 18

Number of Products by Stage and Mechanism of Action, H1 2015 19

Number of Products by Stage and Molecule Type, H1 2015 21

Botulism-Dormant Projects, H1 2015 31

Botulism-Discontinued Products, H1 2015 32

List of Figures

Number of Products under Development for Botulism, H1 2015 7

Number of Products under Development by Companies, H1 2015 9

Comparative Analysis by Early Stage Products, H1 2015 10

Assessment by Monotherapy Products, H1 2015 17

Number of Products by Stage and Top 10 Targets, H1 2015 18

Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 19

Number of Products by Top 10 Molecule Types, H1 2015 20

Number of Products by Stage and Top 10 Molecule Types, H1 2015 21

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

AlphaVax, Inc.

Hawaii Biotech, Inc.

Microbiotix, Inc.

Molecular Targeting Technologies, Inc.

Planet Biotechnology Inc.

Botulism Therapeutic Products under Development, Key Players in Botulism Therapeutics, Botulism Pipeline Overview, Botulism Pipeline, Botulism Pipeline Assessment

select a license

Single User License
USD 2000 INR 135980
Site License
USD 4000 INR 271960
Corporate User License
USD 6000 INR 407940



Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]